Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bromide is a halide anion that serves as an essential trace element and a historical pharmacological agent. It is a required cofactor for the enzyme peroxidasin, which catalyzes the formation of sulfilimine cross-links in collagen IV, a process vital for the structural integrity of basement membranes (McCall et al., 2014). In a clinical context, bromide salts were the first effective treatments for epilepsy and were widely used as sedatives in the 19th century. The ion's therapeutic effect stems from its ability to mimic chloride; it passes through GABA-gated chloride channels more readily than chloride, resulting in neuronal hyperpolarization and an increased seizure threshold (StatPearls). While largely replaced by modern anticonvulsants in humans, it remains a common treatment for canine epilepsy. Chronic use can lead to bromism, a toxic condition characterized by neurological symptoms, psychiatric disturbances, and skin rashes known as bromoderma (NIH). Its long elimination half-life of approximately 12 days presents a significant therapeutic challenge in maintaining stable concentrations (PubChem).
Bromide acts as a chloride analog that competes with chloride for transport across neuronal membranes. It is transported into neurons via GABA-A receptor-associated chloride channels, where its higher permeability relative to chloride leads to enhanced hyperpolarization and reduced neuronal excitability (StatPearls). Additionally, bromide is an essential cofactor for the enzyme peroxidasin, which uses it to generate hypobromous acid to form sulfilimine bonds that cross-link collagen IV in basement membranes (McCall et al., 2014).
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bromide ion (Br-).